Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis

MLA

Min Wang, et al. “Apabetalone, a BET Protein Inhibitor, Inhibits Kidney Damage in Diabetes by Preventing Pyroptosis via Modulating the P300/H3K27ac/PLK1 Axis.” Pharmacological Research, vol. 207, no. 107306-, Sept. 2024. EBSCOhost, https://doi.org/10.1016/j.phrs.2024.107306.

APA

Min Wang, Zhaohui Huang, Xin Li, Ping He, He Sun, Yali Peng, & QiuLing Fan. (2024). Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis. Pharmacological Research, 207(107306-). https://doi.org/10.1016/j.phrs.2024.107306

Chicago

Min Wang, Zhaohui Huang, Xin Li, Ping He, He Sun, Yali Peng, and QiuLing Fan. 2024. “Apabetalone, a BET Protein Inhibitor, Inhibits Kidney Damage in Diabetes by Preventing Pyroptosis via Modulating the P300/H3K27ac/PLK1 Axis.” Pharmacological Research 207 (107306-). doi:10.1016/j.phrs.2024.107306.